Global Mouth Ulcer Treatment Market Research Report: By Drug Type (Corticosteroid, Antihistamine, Antimicrobial, Analgesic, & Others), by Formulations (Gel, Mouthwash, Spray, & Others), by Indication (Aphthous Stomatitis, and Others) – Forecast Till 2023
ID: MRFR/Pharma/4960-HCR | February 2021 | Region: Global | 90 pages
Market Scenario
The global mouth ulcer treatment market is expected to grow significantly over the forecast period. It is estimated that the mouth ulcer treatment market is expected to register a CAGR of ~ 4 % during the forecast period from 2018 to 2023.
Mouth ulcers are painful sores that can develop in the mucous membrane of the oral cavity and this restrict the ability to chew, bite or eat. Some factors which result in mouth ulcer are stress, infection, injury, allergy, and others which leads to intense pain. Increasing use of synthetics in oral items such as toothpaste and growing unhealthy lifestyle, including high consumption of junk food and tobacco are some of the factors driving the growth of this market. Mouth ulcer can be prevented by avoiding tissue injury, avoiding the food that causes irritation in mouth and maintaining oral hygiene. Besides the traditional method, various drugs are used to treat mouth ulcer. Increasing aging population and increasing incidences of mouth ulcer are driving the growth of this market.
However, people have a very casual approach towards mouth ulcer, which can lead to negative impact on the growth of the market in future.
Segmentation
The global mouth ulcer treatment market has been segmented on basis of drug type, formulation, and indication. On basis of drug type, the market is segmented into corticosteroid, antihistamine, antimicrobial, analgesic, and anesthetic. Based on formulation, the mouth ulcer treatment market is segmented into gel, mouthwash, ointment, spray, and lozenges. Based on indication mouth ulcer treatment market is segmented into Aphthous Stomatitis, Oral Lichen Planus and Others.
Key players
Key players in the mouth ulcer treatment market are Pfizer, Inc., Church & Dwight Co., Inc., 3M, Taro Pharmaceutical Industries Ltd., Bristol-Myers Squibb Company, BLISTEX, INC., GlaxoSmithKline plc.,
ECR Pharmaceuticals, Sannova, Reckitt Benckiser, Sunstar, Blairex Laboratories, Sanjin Pharmaceutical, Joincare Pharmaceutical, Sinclair Pharma, Colgate-Palmolive Company
Regional Market Summary
Global Mouth Ulcer Treatment Market Share (%), by Region, 2018
Source: World Health Organization (WHO)
The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The mouth ulcer treatment market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada. The European mouth ulcer treatment market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The mouth ulcer treatment market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The mouth ulcer treatment market in the Middle East and Africa has been segmented into the Middle East and Africa.
On the basis of region, the market is segmented into North America, Europe, Asia-Pacific, and the Middle East and Africa. North America market is anticipated to dominate the mouth ulcer treatment market due to advanced technology made in diagnostic procedures of oral and dental care. Growing awareness among consumers regarding the availability of mouth ulcer treatment is the key share to increase the growth of the market in North America. Europe is anticipated to drive the growth of mouth ulcer treatment in upcoming years due to increasing incidences of an aging population suffering from mouth ulcer. Asia-Pacific is projected to register a robust growth due to increasing initiatives of government regarding mouth ulcer and increasing patients with mouth ulcer cases. The Middle East and Africa is expected to account for the lowest market share in the global mouth ulcer treatment market due to lack of advanced technology and poor medical facilities in developing economies in this region.
Global Mouth Ulcer Treatment Market, by Drug Type
- Corticosteroid
- Antihistamine
- Antimicrobial
- Analgesic
- Anesthetic
Global Mouth Ulcer Treatment Market, by Formulation
- Gel
- Mouthwash
- Ointment
- Spray
- Lozenges
Global Mouth Ulcer Treatment Market, by Indications
- Aphthous Stomatitis
- Oral Lichen Planus
- Others
Global Mouth Ulcer Treatment Market, by Region
- Americas
- North America
- US
- Canada
- South America
- Europe
- Western Europe
- Germany
- France
- Italy
- Spain
- UK
- Rest of Western Europe
- Eastern Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Middle East & Africa
- Middle East
- Africa
Frequently Asked Questions (FAQ) :
Casual approach taken by most patients towards mouth ulcers is the key restraint on the market, as this stops patients from seeking out recognized medication.
Mouth Ulcer Treatment Market is expected to exhibit a steady 4% CAGR over the forecast period from 2018 to 2023.
Growing prevalence of mouth ulcers is likely to be a major driver for the market.
Americas hold the largest share in the global mouth ulcer treatment market.
Leading players in the Mouth Ulcer Treatment Market include BLISTEX Inc., 3M, and Pfizer, among others.
Table of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Mouth Ulcer Treatment Market, by Drug Type
6.1 Introduction
6.2 Corticosteroid
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
6.3 Antihistamine
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
6.4 Antimicrobial
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
6.5 Analgesic
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
6.6 Anesthetic
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
Chapter 7. Global Mouth Ulcer Treatment Market, by Formulation
7.1 Introduction
7.2 Gel
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
7.3 Mouthwash
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
7.4 Ointment
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
7.5 Spray
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
7.6 Lozenges
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
Chapter 8. Global Mouth Ulcer Treatment Market, by Indications
8.1 Introduction
8.2 Aphthous Stomatitis
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–202
8.3 Oral Lichen Planus
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
8.4 Others
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
Chapter 9. Global Cosmetic Dentistry, by Region
9.1 Introduction
9.2 America
9.2.1 North America
9.2.1.1 US
9.2.1.2 Canada
9.2.2 South America
9.3 Europe
9.3.1 Western Europe
9.3.1.1 Germany
9.3.1.2 France
9.3.1.3 Italy
9.3.1.4 Spain
9.3.1.5 UK
9.3.1.6 Rest of Western Europe
9.3.2 Eastern Europe
9.4 Asia-Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia-Pacific
9.5 Middle East & Africa
9.5.1 Middle East
9.5.2 Africa
Chapter 10. Company Landscape
10.1 Introduction
10.2 Market Share Analysis
10.3 Key Development & Strategies
Chapter 11. Company Profiles
11.1 Pfizer, Inc.
11.1.1 Company Overview
11.1.2 Product Overview
11.1.3 Financials Overview
11.1.4 Key Developments
11.1.5 SWOT Analysis
11.2 Church & Dwight Co., Inc
11.2.1 Company Overview
11.2.2 Product Overview
11.2.3 Financial Overview
11.2.4 Key Developments
11.2.5 SWOT Analysis
11.3 3M, Taro Pharmaceutical Industries Ltd
11.3.1 Company Overview
11.3.2 Product Overview
11.3.3 Financial Overview
11.3.4 Key Development
11.3.5 SWOT Analysis
11.4 Bristol-Myers Squibb Company
11.4.1 Company Overview
11.4.2 Product Overview
11.4.3 Financial Overview
11.4.4 Key Development
11.4.5 SWOT Analysis
11.5 BLISTEX, INC
11.5.1 Company Overview
11.5.2 Product Overview
11.5.3 Financial overview
11.5.4 Key Developments
11.5.5 SWOT Analysis
11.6 GlaxoSmithKline plc
11.6.1 Company Overview
11.6.2 Product Overview
11.6.3 Financial Overview
11.6.4 Key Developments
11.6.5 SWOT Analysis
11.7 ECR Pharmaceuticals
11.7.1 Overview
11.7.2 Product Overview
11.7.3 Financial Overview
11.7.4 Key Developments
11.7.5 SWOT Analysis
11. 8 Sannova
11.8.1 Overview
11.8.2 Product Overview
11.8.3 Financials
11.8.4 Key Developments
11.8.5 SWOT Analysis
11. 9 Reckitt Benckiser
11.9.1 Overview
11.9.2 Product Overview
11.9.3 Financials
11.9.4 Key Developments
11.9.5 SWOT Analysis
11.10 Sunstar
11.10.1 Overview
11.10.2 Product Overview
11.10.3 Financials
11.10.4 Key Developments
11.10.5 SWOT Analysis
11.11 Blairex Laboratories
11.12.1 Overview
11.12.2 Product Overview
11.12.3 Financials
11.12.4 Key Developments
11.12.5 SWOT Analysis
11.12 Sanjin Pharmaceutical
11.12.1 Overview
11.12.2 Product Overview
11.12.3 Financials
11.12.4 Key Developments
11.12.5 SWOT Analysis
11. 13 Joincare Pharmaceutical
11. 13.1Overview
11. 13.2Product Overview
11. 13.3Financials
11. 13.4Key Developments
11. 13.5SWOT Analysis
11. 14 Sinclair Pharma
11. 14.1Overview
11. 14.2Product Overview
11. 14.3Financials
11. 14.4Key Developments
11. 14.5SWOT Analysis
11. 15 Colgate-Palmolive Company
11. 15.1Overview
11. 15.2Product Overview
11. 15.3Financials
11. 15.4Key Developments
11. 15.5SWOT Analysis
Chapter 12 MRFR Conclusion
12.1 Key Findings
12.1.1 From CEO’s Viewpoint
12.1.2 Unmet Needs of the Market
12.2 Key Companies to Watch
12.3 Predictions for the Global Mouth Ulcer Treatment Industry
Chapter 13. Appendix
LIST OF TABLES
Table 1 Global Mouth Ulcer Treatment Market Synopsis, 2018–2023
Table 2 Global Mouth Ulcer Treatment Market Estimates and Forecast, 2018–2023 (USD Million)
Table 3 Global Mouth Ulcer Treatment Market, by Drug Type, 2018–2023 (USD Million)
Table 4 Global Mouth Ulcer Treatment Market, by Formulation, 2018–2023 (USD Million)
Table 5 Global Mouth Ulcer Treatment Market, by Indications, 2018–2023 (USD Million)
Table 6 Global Mouth Ulcer Treatment Market, by Region, 2018–2023(USD Million)
Table 7 North America: Mouth Ulcer Treatment Market, by Drug Type, 2018–2023 (USD Million)
Table 8 North America: Mouth Ulcer Treatment Market, by Formulation, 2018–2023 (USD Million)
Table 9 North America: Mouth Ulcer Treatment Market, by Indication, 2018–2023 (USD Million)
Table 10 North America: Mouth Ulcer Treatment Market, by Region, 2018–2023 (USD Million)
Table 8 US: Mouth Ulcer Treatment Market, by Drug Type, 2018–2023 (USD Million)
Table 11 US: Mouth Ulcer Treatment Market, by Formulation, 2018–2023 (USD Million)
Table 12 US: Mouth Ulcer Treatment Market, by Indication, 2018–2023 (USD Million)
Table 13 US: Mouth Ulcer Treatment Market, by Region, 2018–2023 (USD Million)
Table 13 Canada: Mouth Ulcer Treatment Market, by Drug Type, 2018–2023 (USD Million)
Table 14 Canada: Mouth Ulcer Treatment Market, by Formulation, 2018–2023 (USD Million)
Table 17 Canada: Mouth Ulcer Treatment Market, by Indication, 2018–2023 (USD Million)
Table 15 Canada: Mouth Ulcer Treatment Market, by Region, 2018–2023 (USD Million)
Table 19 South America: Mouth Ulcer Treatment Market, by Drug Type, 2018–2023 (USD Million)
Table 20 South America: Mouth Ulcer Treatment Market, by Formulation, 2018–2023 (USD Million)
Table 21 South America: Mouth Ulcer Treatment Market, by Indication, 2018–2023 (USD Million)
Table 22 South America: Mouth Ulcer Treatment Market, by Region, 2018–2023 (USD Million)
Table 23 Europe: Mouth Ulcer Treatment Market, by Drug Type, 2018–2023 (USD Million)
Table 24 Europe: Mouth Ulcer Treatment Market, by Formulation, 2018–2023 (USD Million)
Table 25 Europe: Mouth Ulcer Treatment Market, by Indication, 2018–2023 (USD Million)
Table 26 Europe: Mouth Ulcer Treatment Market, by Region, 2018–2023 (USD Million)
Table 27 Western Europe: Mouth Ulcer Treatment Market, by Drug Type, 2018–2023 (USD Million)
Table 28 Western Europe: Mouth Ulcer Treatment Market, by Formulation, 2018–2023 (USD Million)
Table 29 Western Europe: Mouth Ulcer Treatment Market, by Indication, 2018–2023 (USD Million)
Table 30 Western Europe: Mouth Ulcer Treatment Market, by Region, 2018–2023 (USD Million)
Table 31 Eastern Europe: Mouth Ulcer Treatment Market, by Drug Type, 2018–2023 (USD Million)
Table 32 Eastern Europe: Mouth Ulcer Treatment Market, by Formulation, 2018–2023 (USD Million)
Table 33 Eastern Europe: Mouth Ulcer Treatment Market, by Indication, 2018–2023 (USD Million)
Table 34 Eastern Europe: Mouth Ulcer Treatment Market, by Region, 2018–2023 (USD Million)
Table 35 Asia-Pacific: Mouth Ulcer Treatment Market, by Drug Type, 2018–2023 (USD Million)
Table 36 Asia-Pacific: Mouth Ulcer Treatment Market, by Formulation, 2018–2023 (USD Million)
Table 37 Asia-Pacific: Mouth Ulcer Treatment Market, by Indication, 2018–2023 (USD Million)
Table 38 Asia-Pacific: Mouth Ulcer Treatment Market, by Region, 2018–2023 (USD Million)
Table 39 Middle East & Africa: Mouth Ulcer Treatment Market, by Drug Type, 2018–2023 (USD Million)
Table 40 Middle East & Africa: Mouth Ulcer Treatment Market, by Formulation, 2018–2023 (USD Million)
Table 41 Middle East & Africa: Mouth Ulcer Treatment Market, by Indication, 2018–2023 (USD Million)
Table 42 Middle East & Africa: Mouth Ulcer Treatment Market, by Region, 2018–2023 (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Mouth Ulcer Treatment Market
Figure 3 Segmentation Market Dynamics for Global Mouth Ulcer Treatment Market
Figure 4 Global Mouth Ulcer Treatment Market Share, by Drug Type, 2018(%)
Figure 5 Global Mouth Ulcer Treatment Market Share, by Formulation, 2018(%)
Figure 6 Global Mouth Ulcer Treatment Market Share, by Indications, 2018(%)
Figure 7 Global Mouth Ulcer Treatment Market Share, by Region, 2018(%)
Figure 8 North America: Mouth Ulcer Treatment Market Share, by Country, 2018(%)
Figure 9 Europe: Mouth Ulcer Treatment Market Share, by Country, 2018(%)
Figure 10 Asia-Pacific: Mouth Ulcer Treatment Market Share, by Country, 2018(%)
Figure 11 Middle East & Africa: Mouth Ulcer Treatment Market Share, by Country, 2018(%)
Figure 12 Global Mouth Ulcer Treatment Market: Company Share Analysis, 2018(%)
Figure 13 Pfizer, Inc: Key Financials
Figure 14 Pfizer, Inc: Segmental Revenue
Figure 15 Pfizer, Inc: Geographical Revenue
Figure 16 Church & Dwight Co., Inc: Key Financials
Figure 17 Church & Dwight Co., Inc: Segmental Revenue
Figure 18 Church & Dwight Co., Inc: Geographical Revenue
Figure 19 3M, Taro Pharmaceutical Industries Ltd: Key Financials
Figure 20 3M, Taro Pharmaceutical Industries Ltd: Segmental Revenue
Figure 21 3M, Taro Pharmaceutical Industries Ltd: Geographical Revenue
Figure 22 Bristol-Myers Squibb Company: Key Financials
Figure 23 Bristol-Myers Squibb Company: Segmental Revenue
Figure 24 Bristol-Myers Squibb Company: Geographical Revenue
Figure 25 BLISTEX, INC.: Key Financials
Figure 26 BLISTEX, INC.: Segmental Revenue
Figure 27 BLISTEX, INC.: Geographical Revenue
Figure 28 GlaxoSmithKline plc.: Key Financials
Figure 29 GlaxoSmithKline plc.: Segmental Revenue
Figure 30 GlaxoSmithKline plc.: Geographical Revenue
Figure 31 ECR Pharmaceuticals: Key Financials
Figure 32 ECR Pharmaceuticals: Segmental Revenue
Figure 33 ECR Pharmaceuticals: Geographical Revenue
Figure 34 Sannova: Key Financials
Figure 35 Sannova: Segmental Revenue
Figure 36 Sannova: Geographical Revenue
Figure 37 Reckitt Benckiser: Key Financials
Figure 38 Reckitt Benckiser: Segmental Revenue
Figure 39 Reckitt Benckiser: Geographical Revenue
Figure 40 Sunstar: Key Financials
Figure 41 Sunstar: Segmental Revenue
Figure 42 Sunstar: Geographical Revenue
Figure 43 Blairex Laboratories: Key Financials
Figure 44 Blairex Laboratories: Segmental Revenue
Figure 45 Blairex Laboratories: Geographical Revenue
Figure 46 Sanjin Pharmaceutical: Key Financials
Figure 47 Sanjin Pharmaceutical: Segmental Revenue
Figure 48 Sanjin Pharmaceutical: Geographical Revenue
Figure 49 Joincare Pharmaceutical.: Key Financials
Figure 50 Joincare Pharmaceutical.: Segmental Revenue
Figure 51 Joincare Pharmaceutical.: Geographical Revenue
Figure 52 Sinclair Pharma: Key Financials
Figure 53 Sinclair Pharma: Segmental Revenue
Figure 54 Sinclair Pharma: Geographical Revenue
Figure 55 Colgate-Palmolive Company: Key Financials
Figure 56 Colgate-Palmolive Company: Segmental Revenue
Figure 57 Colgate-Palmolive Company: Geographical Revenue
